Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    17369569 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Radiation: iobenguane I 131
2 Temporarily not available A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
Conditions: Neuroblastoma;   Pheochromocytoma
Intervention: Drug: 131-I-meta-iodobenzylguanidine
3 Not yet recruiting Phase I Study of Investigational Medicinal Products in Children With Relapsed/Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Nivolumab;   Drug: Ch14.18/CHO

Study has passed its completion date and status has not been verified in more than two years.